management of Barrett’s esophagitis
PPI.
W/o dysplasia:
surveillance EGD q3–5y.
Low-grade dysplasia:
EGD q12mo; possible endoscopic eradication.
High-grade dysplasia:
endoscopic eradication; consider chemoprophylaxis w/ high-dose PPI & ASA (Lancet 2018;392:400).